Xiao‐Feng Zhu

4.1k total citations · 1 hit paper
105 papers, 2.5k citations indexed

About

Xiao‐Feng Zhu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiao‐Feng Zhu has authored 105 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 20 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Xiao‐Feng Zhu's work include Autophagy in Disease and Therapy (10 papers), Microbial Natural Products and Biosynthesis (7 papers) and RNA modifications and cancer (6 papers). Xiao‐Feng Zhu is often cited by papers focused on Autophagy in Disease and Therapy (10 papers), Microbial Natural Products and Biosynthesis (7 papers) and RNA modifications and cancer (6 papers). Xiao‐Feng Zhu collaborates with scholars based in China, United States and Hong Kong. Xiao‐Feng Zhu's co-authors include Rong Deng, Gong‐Kan Feng, Yuhong Chen, Hai‐Liang Zhang, Zhi‐Ling Li, Yun Huang, Bingxin Hu, Xiao-Dan Peng, Dajun Yang and Tian Du and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiao‐Feng Zhu

98 papers receiving 2.5k citations

Hit Papers

PKCβII phosphorylates ACS... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao‐Feng Zhu China 26 1.4k 624 536 426 416 105 2.5k
Fei Chen China 30 1.9k 1.4× 472 0.8× 245 0.5× 521 1.2× 415 1.0× 114 3.3k
Jian Hu United States 35 2.6k 1.9× 962 1.5× 377 0.7× 582 1.4× 232 0.6× 104 4.3k
Li Cai China 32 1.7k 1.2× 802 1.3× 524 1.0× 807 1.9× 349 0.8× 159 3.3k
Hongyu Liu China 27 1.3k 0.9× 609 1.0× 407 0.8× 413 1.0× 143 0.3× 168 2.3k
Seiji Masuda Japan 31 2.7k 2.0× 524 0.8× 236 0.4× 842 2.0× 365 0.9× 87 6.0k
Song Iy Han South Korea 30 1.6k 1.2× 721 1.2× 269 0.5× 837 2.0× 299 0.7× 75 2.9k
Borros Arneth Germany 19 832 0.6× 345 0.6× 285 0.5× 510 1.2× 176 0.4× 96 2.3k
Stefania Gelmini Italy 35 1.3k 1.0× 716 1.1× 229 0.4× 528 1.2× 428 1.0× 79 2.9k
Yuh‐Shan Jou Taiwan 36 2.7k 1.9× 908 1.5× 440 0.8× 791 1.9× 243 0.6× 78 3.9k
Liantao Li China 27 1.2k 0.9× 368 0.6× 280 0.5× 869 2.0× 209 0.5× 115 2.9k

Countries citing papers authored by Xiao‐Feng Zhu

Since Specialization
Citations

This map shows the geographic impact of Xiao‐Feng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Feng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Feng Zhu more than expected).

Fields of papers citing papers by Xiao‐Feng Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Feng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Feng Zhu. The network helps show where Xiao‐Feng Zhu may publish in the future.

Co-authorship network of co-authors of Xiao‐Feng Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Feng Zhu. A scholar is included among the top collaborators of Xiao‐Feng Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Feng Zhu. Xiao‐Feng Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shan, Jia‐Lu, Zhi‐Ling Li, Yun Huang, et al.. (2025). Reactivating cGAS–STING Signaling by Targeting SOS1 Enhances Antitumor Immunity in NRAS -Mutant Tumors. Cancer Research. 85(16). 3015–3031.
2.
Lin, Qing, Honghao Huang, Yun Zou, et al.. (2025). Delivery of miR-29a/29c-3p by serum exosomes promotes osteogenesis through TET3-dependent Sox9 demethylation and PI3K/Akt activation. Journal of Nanobiotechnology. 23(1). 751–751.
3.
Liang, Ziwen, Wei-Wen Lin, Yan Li, et al.. (2025). Aqueous extract of Rehmanniae Radix Praeparata improves bone health in ovariectomized rats by modulating the miR-29a-3p/NFIA/Wnt signaling pathway axis. Journal of Ethnopharmacology. 344. 119549–119549. 2 indexed citations
4.
Zhu, Xiao‐Feng, et al.. (2025). Association between RAR and the prevalence and prognosis of depression: A population-based study. Journal of Affective Disorders. 380. 1–9. 1 indexed citations
5.
Zhang, Hai‐Liang, Bingxin Hu, Zhi‐Ling Li, et al.. (2024). TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer. Science Translational Medicine. 16(753). eadk0330–eadk0330. 32 indexed citations
6.
Hu, Xueling, Wei-Wen Lin, Xiaoyun Li, et al.. (2024). Quercetin promotes osteogenic differentiation of bone marrow mesenchymal stem cells by modulating the miR-214-3p/Wnt3a/β-catenin signaling pathway. Experimental Cell Research. 444(2). 114386–114386. 2 indexed citations
7.
Zhong, Xiaogang, et al.. (2024). Nrf2 pathway activation promotes the expression of genes related to glutathione metabolism in alcohol-exposed astrocytes. PeerJ. 12. e17541–e17541. 1 indexed citations
8.
Li, Zeyu, Yan Wang, Tian Du, et al.. (2024). Inactivated cGAS‐STING Signaling Facilitates Endocrine Resistance by Forming a Positive Feedback Loop with AKT Kinase in ER+HER2– Breast Cancer. Advanced Science. 11(35). e2403592–e2403592. 18 indexed citations
10.
Zhu, Xiao‐Feng, et al.. (2023). Inhibition of TGF-β2–Induced Trabecular Meshwork Fibrosis by Pirfenidone. Translational Vision Science & Technology. 12(11). 21–21. 4 indexed citations
11.
Liu, Shan, Hai‐Liang Zhang, Jing Li, et al.. (2023). Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis. Redox Biology. 62. 102677–102677. 71 indexed citations
12.
Yang, Dong, Mei-Han Duan, Zhi‐Ling Li, et al.. (2023). Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors. Journal of Translational Medicine. 21(1). 586–586. 4 indexed citations
13.
Zhang, Hai‐Liang, Bingxin Hu, Zhi‐Ling Li, et al.. (2022). PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nature Cell Biology. 24(1). 88–98. 394 indexed citations breakdown →
14.
Deng, Rong, Tingting Liu, Zijia Wang, et al.. (2019). Selective C−N Bond Cleavage of N‐Acylisatins: Towards High Performance Acylation/Arylation/Transamination Reagents. Advanced Synthesis & Catalysis. 361(23). 5383–5391. 21 indexed citations
15.
Zhu, Guanyu, et al.. (2019). KLF7 overexpression in bone marrow stromal stem cells graft transplantation promotes sciatic nerve regeneration. Journal of Neural Engineering. 16(5). 56011–56011. 23 indexed citations
16.
Xu, Yaodong, Qian Cai, Gong‐Kan Feng, et al.. (2016). Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells. Oncology Letters. 12(5). 3598–3608. 27 indexed citations
17.
Zhang, Peng, Yiqing Zhao, Xiao‐Feng Zhu, et al.. (2011). Cross-talk between Phospho-STAT3 and PLCγ1 Plays a Critical Role in Colorectal Tumorigenesis. Molecular Cancer Research. 9(10). 1418–1428. 29 indexed citations
18.
Zhao, Peng, Rongcheng Luo, Jiangxue Wu, et al.. (2008). E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases. Journal of Cellular and Molecular Medicine. 14(1-2). 381–391. 10 indexed citations
19.
Zhao, Yanyan, et al.. (2007). Effective Management of Main Bronchial Rupture in Patients with Chest Trauma. The Thoracic and Cardiovascular Surgeon. 55(7). 447–449. 4 indexed citations
20.
Wu, Jiangxue, Xia Xiao, Gang Xue, et al.. (2006). Minicircle-IFNγ Induces Antiproliferative and Antitumoral Effects in Human Nasopharyngeal Carcinoma. Clinical Cancer Research. 12(15). 4702–4713. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026